Welcome to our dedicated page for Xos SEC filings (Ticker: XOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xos, Inc. filings document the public-company record for an electric commercial vehicle and fleet electrification business. Recent Form 8-K reports disclose operating results and financial condition, material agreements, equity financing arrangements, convertible promissory note amendments, facility lease matters, and changes in board composition.
The company's proxy materials describe annual meeting governance, director matters, executive compensation, equity awards, and pay-versus-performance information. Other disclosures identify its Nasdaq-listed common stock and warrants, share issuance limits, at-the-market common stock sales, and exhibits tied to contracts and press releases.
Mattson George N reported acquisition or exercise transactions in this Form 4 filing.
Xos, Inc. director George N. Mattson received an equity award of 60,584 restricted stock units, each representing a contingent right to one share of common stock. These RSUs vest on the earlier of the first anniversary of the grant date and the day before the 2027 annual meeting, subject to his continuous service. Following this grant, he holds 192,346 common shares directly, including the unvested RSUs, and has indirect interests in 131,250 and 33,333 shares through NGAC GNM Feeder LLC and GNM ICBC LLC, for which he disclaims beneficial ownership beyond his pecuniary interest.
RAPP EDWARD J reported acquisition or exercise transactions in this Form 4 filing.
Xos, Inc. director Edward J. Rapp received equity compensation in the form of restricted stock units. He was granted 60,584 RSUs that vest on the earlier of the first anniversary of the grant date or the day before the 2027 annual meeting, subject to continued service, and 2,670 RSUs issued in lieu of his second-quarter 2026 cash retainer as a non-employee director and Audit Committee Chair, which vested immediately on grant. He also reports 21,172 shares of common stock held indirectly through a trust for which he serves as trustee.
Smith John F. reported acquisition or exercise transactions in this Form 4 filing.
Xos, Inc. director Smith John F. received a grant of 60,584 Restricted Stock Units, each representing one share of common stock upon settlement. These RSUs vest on the earlier of the first anniversary of the grant date or the day before the 2027 Annual Meeting, subject to the reporting person's continuous service, and bring direct holdings to 113,562 shares, including 60,584 unvested RSUs.
Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 2,000 shares of Common Stock on June 30, 2026 at $2.89 per share. After this transaction, he directly holds 82,058 shares.
The filing also shows an additional 4,133 shares of Common Stock held indirectly through Bernstein Investment Partners LLC, of which he is the Managing Member, according to the footnote. Within this filing, the sale represents a small fraction of his reported shareholdings.
Xos, Inc. reported the results of its 2026 annual stockholder meeting, where 6,338,211 shares were represented, or 52.57% of the 12,056,211 shares outstanding as of April 24, 2026. Stockholders elected three Class II directors to serve until the 2029 annual meeting and ratified Grant Thornton LLP as independent auditors for 2026.
They approved an amendment to the 2021 Equity Incentive Plan to increase the share reserve by 3,740,000 shares and supported 2025 executive compensation on a non-binding advisory basis. Stockholders also advised holding future say-on-pay votes every three years.
In addition, stockholders approved the potential issuance of 20% or more of the company’s common stock, possibly below the Nasdaq Minimum Price, to holders of certain Convertible Promissory Notes, and approved any related change of control that may be deemed to occur.
Xos, Inc. is offering shares of its common stock having an aggregate offering price of up to $8,779,902 through an at-the-market program with Roth Capital Partners acting as sales agent, pursuant to a Sales Agreement dated June 22, 2026.
The Sales Agreement permits sales from time to time; Roth Capital Partners will receive 3.0% of gross proceeds as compensation. Proceeds are intended for working capital, debt servicing and general corporate purposes and sales are subject to General Instruction I.B.6 to Form S-3 limiting primary offerings to one-third of public float while below $75,000,000. Shares outstanding were 13,718,819 as of June 17, 2026; an illustrative scenario assumes issuance of 2,593,767 shares at $3.385 per share for the full permitted amount.